Rhone Ma Holdings Berhad (KLSE:RHONEMA)

Malaysia · Delayed Price · Currency is MYR

0.6700

-0.0050 (-0.74%)

At close: Sep 21, 2026

Market Cap	149.38M +1.2%
Revenue (ttm)	228.88M +10.0%
Net Income	14.43M +9.7%
EPS	0.06 +26.9%
Shares Out	221.30M
PE Ratio	12.20
Forward PE	9.59
Dividend	0.03 (3.73%)
Ex-Dividend Date	Jun 25, 2026

Volume	10,000
Open	0.6700
Previous Close	0.6750
Day's Range	0.6700 - 0.6700
52-Week Range	0.6200 - 0.7250
Beta	0.15
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2026

About Rhone Ma Holdings Berhad

Rhone Ma Holdings Berhad, an investment holding company, engages in the manufacture, trading, marketing, and distribution of biotechnology and animal health products primarily in Malaysia. The company operates through Animal Health Products and Food Equipment; Food Ingredients; and others segments. It offers diagnostic laboratory analysis and consultation services to veterinary, agriculture, and food industries; tests and diagnostics services for human healthcare; and veterinary advisory services, as well as trades in animal health products. Th... [Read more]

Industry Pharmaceutical Preparations

Founded 2000

Employees 205

Stock Exchange Bursa Malaysia

Ticker Symbol RHONEMA

Full Company Profile

Financial Performance

In 2025, Rhone Ma Holdings Berhad's revenue was 223.68 million, an increase of 5.81% compared to the previous year's 211.41 million. Earnings were 14.16 million, an increase of 15.07%.

Financial Statements